Understanding the Health System Conditions Affecting the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia in Clinical Practice: A US Healthcare Provider Survey

PURPOSE: To describe factors that enable the routine use of long-acting injectable antipsychotics (LAIs) for appropriate patients in the current clinical practice, including changes in LAI prescribing due to the COVID-19 pandemic and expectations for prescribing in 2021 in the United States (US). ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhdanava, Maryia, Starr, H Lynn, Lefebvre, Patrick, Totev, Todor I, Shah, Aditi, Sheng, Kristy, Pilon, Dominic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326898/
https://www.ncbi.nlm.nih.gov/pubmed/35910684
http://dx.doi.org/10.2147/NDT.S369494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326898/
https://www.ncbi.nlm.nih.gov/pubmed/35910684
http://dx.doi.org/10.2147/NDT.S369494

Ejemplares similares